240 related articles for article (PubMed ID: 25632198)
1. Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma.
Zhang LQ; Xu XS; Wan Y; Song SD; Wang RT; Chen W; Wang ZX; Chang HL; Wei JC; Dong YF; Liu C
World J Gastroenterol; 2015 Jan; 21(4):1243-50. PubMed ID: 25632198
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer.
Tao F; Ye MF; Sun AJ; Lv JQ; Xu GG; Jing YM; Wang W
World J Gastroenterol; 2014 Jul; 20(28):9564-9. PubMed ID: 25071353
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of preoperative platelet count in patients with gallbladder cancer.
Wang RT; Zhang LQ; Mu YP; Li JB; Xu XS; Pang Q; Sun LK; Zhang X; Dong SB; Wang L; Liu C
World J Gastroenterol; 2015 May; 21(17):5303-10. PubMed ID: 25954104
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.
Zhang L; Wang R; Chen W; Xu X; Dong S; Fan H; Liu C
HPB (Oxford); 2016 Jul; 18(7):600-7. PubMed ID: 27346141
[TBL] [Abstract][Full Text] [Related]
5. Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinoma.
Nagano M; Hatakeyama K; Kai M; Nakamura H; Yodoi J; Asada Y; Chijiiwa K
HPB (Oxford); 2012 Sep; 14(9):573-82. PubMed ID: 22882193
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
Wu ZC; Xiong L; Wang LX; Miao XY; Liu ZR; Li DQ; Zou Q; Liu KJ; Zhao H; Yang ZL
World J Gastroenterol; 2017 Apr; 23(14):2601-2612. PubMed ID: 28465645
[TBL] [Abstract][Full Text] [Related]
7. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma.
Yuan LW; Liu DC; Yang ZL
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma.
Sun XN; Cao WG; Wang X; Wang Q; Gu BX; Yang QC; Hu JB; Liu H; Zheng S
Tumour Biol; 2011 Dec; 32(6):1183-90. PubMed ID: 21853312
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.
Zou Q; Yang ZL; Yuan Y; Li JH; Liang LF; Zeng GX; Chen SL
World J Surg Oncol; 2013 Jun; 11():143. PubMed ID: 23782473
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma.
Letelier P; Garcia P; Leal P; Ili C; Buchegger K; Riquelme I; Sandoval A; Tapia O; Roa JC
Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):530-6. PubMed ID: 24185122
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Vascular Endothelial Growth Factor and Somatostatin Receptor with Progression and Prognosis in Gastric Cancer.
Zhao DQ; Chen J; Wu YF; Tian D; Zhou RX
Hepatogastroenterology; 2014 Jun; 61(132):1154-8. PubMed ID: 26158180
[TBL] [Abstract][Full Text] [Related]
12. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?
Hari DM; Howard JH; Leung AM; Chui CG; Sim MS; Bilchik AJ
HPB (Oxford); 2013 Jan; 15(1):40-8. PubMed ID: 23216778
[TBL] [Abstract][Full Text] [Related]
13. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma.
Pang Q; Zhang LQ; Wang RT; Bi JB; Zhang JY; Qu K; Liu SS; Song SD; Xu XS; Wang ZX; Liu C
World J Gastroenterol; 2015 Jun; 21(21):6675-83. PubMed ID: 26074706
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of VEGF, PDGF-B, and HER2/neu expression in gallbladder cancer.
Shukla P; Mishra K; Shukla R; Vishwakarma R; Kumari N; Krishnani N; Behari A; Kapoor VK
J Cancer Res Ther; 2024 Jan; 20(1):349-357. PubMed ID: 38554345
[TBL] [Abstract][Full Text] [Related]
15. NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma.
Song SP; Zhang SB; Liu R; Yao L; Hao YQ; Liao MM; Zhang YD; Li ZH
Med Oncol; 2012 Sep; 29(3):1879-85. PubMed ID: 22135002
[TBL] [Abstract][Full Text] [Related]
16. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.
Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838
[TBL] [Abstract][Full Text] [Related]
17. Effect of lymphadenectomy on the prognosis for N0 gallbladder carcinoma patients: A study based on SEER database.
Wu B; Shen Y; Chen X; Wang X; Zhong Z
Cancer Med; 2021 Oct; 10(20):7136-7143. PubMed ID: 34519168
[TBL] [Abstract][Full Text] [Related]
18. Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer.
Xie Y; Lin JZ; Wang AQ; Xu WY; Long JY; Luo YF; Shi J; Liang ZY; Sang XT; Zhao HT
World J Gastroenterol; 2017 Aug; 23(31):5787-5797. PubMed ID: 28883705
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of TROP2 expression in patients with gallbladder cancer.
Chen MB; Wu HF; Zhan Y; Fu XL; Wang AK; Wang LS; Lei HM
Tumour Biol; 2014 Nov; 35(11):11565-9. PubMed ID: 25135430
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients.
Xu WY; Zhang HH; Yang XB; Bai Y; Lin JZ; Long JY; Xiong JP; Zhang JW; Sang XT; Zhao HT
World J Gastroenterol; 2018 Apr; 24(13):1451-1463. PubMed ID: 29632426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
